234 related articles for article (PubMed ID: 22487610)
1. Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease.
Isakova T
Curr Opin Nephrol Hypertens; 2012 May; 21(3):334-40. PubMed ID: 22487610
[TBL] [Abstract][Full Text] [Related]
2. Update on fibroblast growth factor 23 in chronic kidney disease.
Wolf M
Kidney Int; 2012 Oct; 82(7):737-47. PubMed ID: 22622492
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 and the future of phosphorus management.
Wolf M
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):463-8. PubMed ID: 19770756
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and the heart.
Faul C
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):369-75. PubMed ID: 22531163
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
[TBL] [Abstract][Full Text] [Related]
6. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.
Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ
Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672
[TBL] [Abstract][Full Text] [Related]
7. FGF23: a mature renal and cardiovascular risk factor?
Zoccali C; Yilmaz MI; Mallamaci F
Blood Purif; 2013; 36(1):52-7. PubMed ID: 23735695
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
Isakova T; Xie H; Yang W; Xie D; Anderson AH; Scialla J; Wahl P; Gutiérrez OM; Steigerwalt S; He J; Schwartz S; Lo J; Ojo A; Sondheimer J; Hsu CY; Lash J; Leonard M; Kusek JW; Feldman HI; Wolf M;
JAMA; 2011 Jun; 305(23):2432-9. PubMed ID: 21673295
[TBL] [Abstract][Full Text] [Related]
9. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease.
Negri AL
Int Urol Nephrol; 2014 Jan; 46(1):9-17. PubMed ID: 23296792
[TBL] [Abstract][Full Text] [Related]
11. The role of fibroblast growth factor-23 in cardiorenal syndrome.
Kovesdy CP; Quarles LD
Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
[TBL] [Abstract][Full Text] [Related]
12. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
[TBL] [Abstract][Full Text] [Related]
13. Advances in the use of multimarker panels for renal risk stratification.
Weekley CC; Peralta CA
Curr Opin Nephrol Hypertens; 2012 May; 21(3):301-8. PubMed ID: 22449944
[TBL] [Abstract][Full Text] [Related]
14. Is fibroblast growth factor 23 a harbinger of mortality in CKD?
Stubbs JR; Egwuonwu S
Pediatr Nephrol; 2012 May; 27(5):697-703. PubMed ID: 21390563
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
[TBL] [Abstract][Full Text] [Related]
16. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
Jovanovich A; You Z; Isakova T; Nowak K; Cheung A; Wolf M; Chonchol M; Kendrick J
Am J Nephrol; 2019; 49(4):263-270. PubMed ID: 30820005
[TBL] [Abstract][Full Text] [Related]
20. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
